Search company, investor...

ClearCount Medical Solutions

clearcount.com

Founded Year

2004

Stage

Acquired | Acquired

Total Raised

$16.84M

About ClearCount Medical Solutions

ClearCount Medical Solutions is a medical device company focused on patient safety solutions. ClearCount has assembled an extendable RFID-based platform that aims to provide a solution to drive efficiency while preventing medical errors. ClearCount's SmartSponge System is the only FDA-cleared RFID enabled system for counting and detecting surgical sponges. The SmartSponge System is a reconciliation and detection solution that aims to improve patient and O.R. safety, enhances operational efficiency, and aims to reduce cost. In 2014, ClearCount Medical Solutions was acquired by Stryker. The terms of the transaction were not disclosed.

Headquarters Location

101 Bellevue Road Suite 300

Pittsburgh, Pennsylvania, 15229,

United States

412-931-7233

Missing: ClearCount Medical Solutions's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ClearCount Medical Solutions's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing ClearCount Medical Solutions

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ClearCount Medical Solutions is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,605 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

ClearCount Medical Solutions Patents

ClearCount Medical Solutions has filed 13 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/24/2013

12/6/2016

Clusters of differentiation, Surgical instruments, Printed circuit board manufacturing, Electronic design, Transcription factors

Grant

Application Date

6/24/2013

Grant Date

12/6/2016

Title

Related Topics

Clusters of differentiation, Surgical instruments, Printed circuit board manufacturing, Electronic design, Transcription factors

Status

Grant

Latest ClearCount Medical Solutions News

ClearCount Medical Solutions’ SmartSponge absorbs errors

Jan 20, 2015

ClearCount Medical Solutions Inc.'s SmartSponge brings sponge-counting into the 21st century through the use of radio frequency identification chips. Blog © Copyright 2015 Innovation Works Innovation Works is the Ben Franklin Technology Partner of Southwestern PA and is supported by the Department of Community and Economic Development. 2000 Technology Drive

ClearCount Medical Solutions Frequently Asked Questions (FAQ)

  • When was ClearCount Medical Solutions founded?

    ClearCount Medical Solutions was founded in 2004.

  • Where is ClearCount Medical Solutions's headquarters?

    ClearCount Medical Solutions's headquarters is located at 101 Bellevue Road, Pittsburgh.

  • What is ClearCount Medical Solutions's latest funding round?

    ClearCount Medical Solutions's latest funding round is Acquired.

  • How much did ClearCount Medical Solutions raise?

    ClearCount Medical Solutions raised a total of $16.84M.

  • Who are the investors of ClearCount Medical Solutions?

    Investors of ClearCount Medical Solutions include Stryker, Draper Triangle Ventures, Corridor Venture Partners, Pittsburgh Life Sciences Greenhouse, Innovation Works and 3 more.

  • Who are ClearCount Medical Solutions's competitors?

    Competitors of ClearCount Medical Solutions include Amsino International, TrueVision Systems, RF Surgical Systems, CardiAQ Valve Technologies, SurgiCount Medical and 13 more.

Compare ClearCount Medical Solutions to Competitors

V
Verimetra

Verimetra aims to make medical instruments "smart" and manufacturers miniature thin film sensors used in medical applications that involve very small high end catheters. The Company designs and manufactures sensors using micro-electromechanical systems (MEMS) technology, which is the only method available that produces sensors small enough to be embedded in surgical devices without changing their basic form or function, allowing the company's customers to sell the same products, now "smart", without requiring the surgeon to use a new device. Verimetra aims to make medical devices "smart" by embedding (US Patent 6,494,882) a variety of small sensors at an place on or within the device. Simply stated, the company make "dumb" metal tools "smart". Examples include forceps, grippers, retractors, drills, and other surgical devices. Through the use of Verimetra's products, medical device manufacturers are able to deliver features and functionality that, depending on the medical procedure, improve outcomes, reduce risk and shorten patient recovery times. Verimetra's new product features are also used by manufacturers to strengthen their market position, enter new markets and maintain gross margins. Verimetra aims to give these manufacturers a way to accomplish these goals by adding features at a low cost without product redesign. Furthermore, in many instances, Verimetra's customers' goals will be met by the transformation of a re-usable product (one-time sale) into a smart disposable product (one sale per procedure).

I
InformMed

InformMed is a medication safety company developing, patenting and commercializing product and service-based solutions for the growing medication error solution market. InformMed is focused on providing nurses and pharmacists with performance support tools that aid in the level of safety for patients, caregivers and healthcare providers. InformMed's patented flagship product, pac2, is a hand-held performance-support system designed to help nurses prevent wrong dose errors at the point of care, a major healthcare concern.

V
Verax Biomedical

Verax Biomedical is the producer of the Platelet PGD Test, a test for bacterial contamination in platelets granted a Safety Measure claim by the FDA. The test can be used to extend the dating of apheresis platelets in plasma, the most common platelet type transfused in the U.S., from 5 to 7 days. This dating extension offers the opportunity for significant cost savings to the blood banking community while preserving a critical life giving resource.

C
C Change Biosciences

C Change Surgical Llc is a medical device company. It had developed the Intratemp Solution Warmer.Introducing IntraTemp, it will take the uncertainty out of surgical fluids. IntraTemp defines the new standard of care in portable controlled-temperature for irrigation and lavage fluids. Instead of warming fluids away from where you are using them, IntraTemp is completely mobile, allowing for a more efficient way to guarantee the correct temperature to your patients. It will reduce risks for your patients and stress for your staff. It puts temperature control where you need it, when you need it. IntraTemp provides temperature data for chartable proof of quality care.

E
Es Vascular

ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures

L
LifePoint

Lifepoint is a medical technology company developing rapid and cost effective, non-invasive, on-site diagnostic products. The Company has developed and will continue to develop patented, proprietary technologies utilizing saliva as a test specimen to provide blood equivalent diagnostic results without the need for blood or urine.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.